US President Donald Trump has announced a new tariff policy targeting imported generic medicines, a move aimed at encouraging pharmaceutical companies to manufacture more drugs within the United States. The decision could have significant consequences for India, which is the world’s largest supplier of generic medicines and a key exporter to the American healthcare market....
